Skip to playerSkip to main contentSkip to footer
  • 11/25/2022
Paxlovid, the pharma giant's flagship Covid drug, gained emergency approval in the US last December to treat high-risk patients - slashing their risk of death by 90 per cent.

VIEW MORE : https://bit.ly/1breakingnews

Recommended